• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

TAKEDA PHARMACEUTICAL CO

Notes

No. Proposition For Against Abstain
1

Approve Allocation of Income, with a Final Dividend of JPY 100

2

Elect Director Julie Kim

3

Elect Director Furuta, Mirano

4

Elect Director Andrew Plump

5

Elect Director Iijima, Masami

6

Elect Director Steven Gillis

7

Elect Director John Maraganore

8

Elect Director Tsusaka, Miki

9

Elect Director Paul Stoffels

10

Elect Director and Audit Committee Member Kimberly A. Reed

11

Elect Director and Audit Committee Member Bruce Broussard

12

Elect Director and Audit Committee Member Kimura, Koichiro

13

Elect Alternate Director and Audit Committee Member Paul Stoffels

14

Approve Annual Bonus